Risk of breast cancer recurrence associated with carbohydrate intake and tissue expression of IGFI receptor

Cancer Epidemiology Biomarkers and Prevention

Volumn 23, Issue 7, 2014, Pages 1273-1279

  Emond, Jennifer A ^a   Pierce, John P ^a   Natarajan, Loki ^a   Gapuz, Laarni R ^a   Nguyen, John ^a   Parker, Barbara A ^a   Varki, Nissi M ^b   Patterson, Ruth E ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CARBOHYDRATE; SOMATOMEDIN C RECEPTOR; TAMOXIFEN; CARBOHYDRATE DIET;

ADULT; ARTICLE; BREAST CANCER; CANCER RECURRENCE; CANCER RISK; CANCER SURVIVOR; CARBOHYDRATE INTAKE; CASE CONTROL STUDY; CONFIDENCE INTERVAL; CONTROLLED STUDY; DIETARY INTAKE; FEMALE; HUMAN; HUMAN TISSUE; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; POSTMENOPAUSE; PRIORITY JOURNAL; AGED; BREAST NEOPLASMS; CARBOHYDRATE DIET; IMMUNOHISTOCHEMISTRY; METABOLISM; MIDDLE AGED; PATHOLOGY; RISK FACTOR; SURVIVOR; TUMOR RECURRENCE;

AGED; BREAST NEOPLASMS; CASE-CONTROL STUDIES; DIETARY CARBOHYDRATES; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; RECEPTOR, IGF TYPE 1; RISK FACTORS; SURVIVORS;

EID: 84903934414     PISSN: 10559965     EISSN: None     Source Type: Journal    
DOI: 10.1158/1055-9965.EPI-13-1218     Document Type: Article

References (34)

1. Howlader N, Noone AM, Yu M, Cronin KA. Use of imputed populationbased cancer registry data as a method of accounting for missing information: application to estrogen receptor status for breast cancer. Am J Epidemiol 2012;176: 347-6.
2. Pierce JP, Natarajan L, Caan BJ, Parker BA, Greenberg ER, Flatt SW, et al. Influence of a diet very high in vegetables, fruit, and fiber and low in fat on prognosis following treatment for breast cancer: the Women's Healthy Eating and Living (WHEL) randomized trial. JAMA 2007; 298: 289-98.
3. Chlebowski RT, Blackburn GL, Thomson CA, Nixon DW, Shapiro A, Hoy MK, et al. Dietary fat reduction and breast cancer outcome: interim efficacy results from the Women's Intervention Nutrition Study. J Natl Cancer Inst 2006;98: 1767-76.
4. Handelsman Y, Leroith D, Bloomgarden ZT, Dagogo-Jack S, Einhorn D, Garber AJ, et al.: Diabetes and Cancer-An AACE/ACE Consensus Statement. Endocr Pract 2013;19: 675-93.
5. Patterson RE, Rock CL, Kerr J, Natarajan L, Marshall SJ, Pakiz B, et al. Metabolism and breast cancer risk: frontiers in research and practice. J Acad Nutr Diet 2013;113: 288-96.
6. Hartog H, Boezen HM, de Jong MM, Schaapveld M, Wesseling J, van der Graaf WT. Prognostic value of insulin-like growth factor 1 and insulin-like growth factor binding protein 3 blood levels in breast cancer. Breast 2013;22: 1155-60.
7. Browne BC, Crown J, Venkatesan N, Duffy MJ, Clynes M, Slamon D, et al. Inhibition of IGF1 receptor activity enhances response to trastuzumab in HER-2-positive breast cancer cells. Ann Oncol 2011;22: 68-73.
8. Law JH, Habibi G, Hu K, Masoudi H, Wang MY, Park E, et al. Phosphorylated insulin-like growth factor-i/insulin receptor is present in all breast cancer subtypes and is related to poor survival. Cancer Res 2008;68: 10238-6.
9. Li P, Veldwijk MR, Zhang Q, Li ZB, Fu S. Co-inhibition of epidermal growth factor receptor and insulin-like growth factor receptor 1 enhances radiosensitivity in human breast cancer cells. BMC Cancer 2013;13: 297.
10. Turner BC, Haffty BG, Narayanan L, Yuan J, Havre PA,GumbsAA, et al. Insulin-like growth factor-I receptor overexpression mediates cellular radioresistance and local breast cancer recurrence after lumpectomy and radiation. Cancer Res 1997;57: 3079-83.
11. Yu H, Rohan T. Role of the insulin-like growth factor family in cancer development and progression. J Natl Cancer Inst 2000;92: 1472-89.
12. Voskuil DW, Vrieling A, van't Veer LJ, Kampman E, Rookus MA. The insulin-like growth factor system in cancer prevention: potential of dietary intervention strategies. Cancer Epidemiol Biomarkers Prev 2005;14: 195-03.
13. Newman VA, Thomson CA, Rock CL, Flatt SW, Kealey S, Bardwell WA, et al. Achieving substantial changes in eating behavior among women previously treated for breast cancer-An overview of the intervention. J Am Diet Assoc 2005;105: 382-91.
14. Bernstein JL, Langholz B, Haile RW, Bernstein L, Thomas DC, Stovall M, et al. Study design: evaluating gene-environment interactions in the etiology of breast cancer -The WECARE study. Breast Cancer Res 2004;6: R199-14.
15. Cologne JB, Sharp GB, Neriishi K, Verkasalo PK, Land CE, Nakachi K. Improving the efficiency of nested case-control studies of interaction by selecting controls using counter matching on exposure. Int J Epidemiol 2004;33: 485-92.
16. Langholz B. Counter-matching: a stratified nested case-control sampling method. Biometrika 2005;82: 69-79.
17. Pierce JP, Faerber S, Wright FA, Rock CL,Newman V, Flatt SW, et al.: A randomized trial of the effect of a plant-based dietary pattern on additional breast cancer events and survival: the Women's Healthy Eating and Living (WHEL) Study. Control Clin Trials 2002;23: 728-6.
18. R Development Core Team. R: A language and environment for statistical computing. 2011; Vienna, Austria: the R Foundation for Statistical Computing. Available from: http://www.R-project.org/.
19. Nielsen TO, Andrews HN, Cheang M, Kucab JE, Hsu FD, Ragaz J, et al. Expression of the insulin-like growth factor I receptor and urokinase plasminogen activator in breast cancer is associated with poor survival: potential for intervention with 17-Allylamino geldanamycin. Cancer Res 2004;64: 286-91.
20. Peir-o G, Adrover E, Sanchez-Tejada L, Lerma E, Planelles M, S-Anchez-Pay-A J, et al. Increased insulin-like growth factor-1 receptor mRNA expression predicts poor survival in immunophenotypes of early breast carcinoma. Mod Pathol 2011;24: 201-8.
21. Railo MJ, von Smitten K, Pekonen F. The prognostic value of insulinlike growth factor-I in breast cancer patients. Results of a follow-up study on 126 patients. Eur J Cancer 1994;30A: 307-1.
22. Bhargava R, Beriwal S, McManus K, Dabbs DJ. Insulin-like growth factor receptor-1 (IGF-1R) expression in normal breast, proliferative breast lesions, and breast carcinoma. Appl Immunohistochem Mol Morphol 2011;19: 218-5.
23. Kim JH, Cho YH, Park YL, Sohn JH, Kim HS. Prognostic significance of insulin growth factor-I receptor and insulin growth factor binding protein-3 expression in primary breast cancer. Oncol Rep 2011;23: 989-95.
24. Schnarr B, Strunz K, Ohsam J, Benner A, Wacker J, Mayer D. Downregulation of insulin-like growth factor-I receptor and insulin receptor substrate-1 expression in advanced human breast cancer. Int J Cancer 2000;89: 506-3.
25. Kalla Singh S, Tan QW, Brito C, De Le-on M, De Le-on D. Insulin-like growth factors I and II receptors in the breast cancer survival disparity among African-American women. Growth Horm IGF Res 2010;20: 245-4.
26. Li CI, Malone KE, Daling Jr. Differences in breast cancer stage, treatment, and survival by race and ethnicity. Arch Intern Med 2003; 163: 49-6.
27. Warburg O. On the origin of cancer cells. Science 1956;123: 309-4.
28. LeRoith D, Roberts CT Jr. The insulin-like growth factor system and cancer. Cancer Lett 2003;195: 127-7.
29. Buyken AE, Flood V, Empson M, Rochtchina E, Barclay AW, Brand-Miller J, et al. Carbohydrate nutrition and inflammatory disease mortality in older adults. Am J Clin Nutr 2010;92: 634-3.
30. Goodwin PJ, Ennis M, Pritchard KI, Trudeau ME, Koo J, Taylor Sk, et al. Insulin-And obesity-related variables in early-stage breast cancer: correlations and time course of prognostic associations. J Clin Oncol 2012;30: 164-71.
31. Pollak M. The insulin and insulin-like growth factor receptor family in neoplasia: an update. Nat Rev Cancer 2012;12: 159-69.
32. Bingham SA, Day N. Commentary: fat and breast cancer: time to reevaluate both methods and results? Int J Epidemiol 2006;35: 1022-4.
33. Freeman LS, Potischman N, Kipnis V, Midthune D, Schatzkin A, Thompson FE, et al. A comparison of two dietary instruments for evaluating the fat-breast cancer relationships. Int J Epidemiol 2006; 35: 1011-1.
34. Kristal AR, Peters U, Potter JD: Is it time to abandon the food frequency questionnaire? Cancer Epidemiol Biomarkers Prev 2005;14: 2826-8.